{{Rsnum
|rsid=10048158
|Chromosome=17
|position=66240200
|Orientation=plus
|GMAF=0.2461
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 27.4 | 52.2 | 20.4
| HCB | 81.5 | 16.3 | 2.2
| JPT | 91.7 | 8.3 | 0.0
| YRI | 93.7 | 6.3 | 0.0
| ASW | 82.5 | 15.8 | 1.8
| CHB | 81.5 | 16.3 | 2.2
| CHD | 84.3 | 14.8 | 0.9
| GIH | 52.0 | 44.0 | 4.0
| LWK | 87.3 | 12.7 | 0.0
| MEX | 43.9 | 49.1 | 7.0
| MKK | 70.3 | 26.5 | 3.2
| TSI | 25.3 | 47.5 | 27.3
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23279374
  |Trait=β2-Glycoprotein I (β2-GPI) plasma levels
  |Title=Genetic determinants of plasma β2 -glycoprotein I levels: a genome-wide association study in extended pedigrees from Spain.
  |RiskAllele=C
  |Pval=1E-6
  |OR=.41
  |ORtxt=(unit decrease)
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA}}
{{on chip | Illumina Human 1M}}